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The impact of sex and gender on disease incidence, progression, and provision of care
has gained increasing attention in many areas of medicine. Biological factors–sex–and
sociocultural and behavioral factors–gender–greatly impact on health and disease.
While sex can modulate disease progression and response to therapy, gender can
influence patient-provider communication, non-pharmacological disease management,
and need for assistance. Sex and gender issues are especially relevant in chronic
progressive diseases, such as Parkinson’s disease (PD), because affected patients
require multidisciplinary care for prolonged periods of time. In this perspective paper,
we draw from evidence in the field of PD and various other areas of medicine to address
how sex and gender could impact PD care provision. We highlight examples for which
differences have been reported and formulate research topics and considerations on
how to optimize the multidisciplinary care of persons with PD.
Keywords: Parkinson’s disease, multidisciplinary care, sex factors, gender, disease progression, male, female,
caregivers
INTRODUCTION
Sex and gender impact disease incidence, progression, and provision of care in different medical
disciplines (1). “Sex” differences are based on biological variations due to differences in genetics,
hormones, and physiology. “Gender” differences are rooted in different expressions of identity,
adherence to norms, and socially defined behaviors (2). Sex can impact the biological bases of
disease progression, response to diagnostics, and therapies, while gender can influence access to
healthcare, coping with disease, compliance with therapies, and patient-provider communication.
Taken together, these aspects warrant consideration in the provision of care to people living with
a disease.
The influences of sex and gender on care delivery are especially relevant for chronic diseases
that are characterized by a heterogeneous and progressive spectrum of clinical features. A prime
example of such a disease is Parkinson’s disease (PD), which is the second most common
neurodegenerative disease worldwide and which demonstrates a rapidly rising prevalence (3). PD
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is partially characterized by motor features, but affected persons
typically also experience a highly variable combination of
non-motor features. Given the multifaceted and heterogenous
nature of the disease, care delivery to people with PD typically
involves healthcare professionals from a wide range of different
professional disciplines to accommodate the specific clinical
features, needs and coping styles of a person with PD (4–7).
Ideally, any person with PD should be treated by a diverse,
multidisciplinary team, consisting of a general practitioner,
neurologist, PD nurse specialist, physiotherapist, occupational
therapist, speech- and language therapist, neuropsychologist,
dietician, or other healthcare professionals, depending on the
needs of the patient (7).
At the time of clinical diagnosis, differences in the prevalence
of motor and non-motor features might exist between men and
women with PD. For instance, men might experience more
rigidity and women more tremor (8). As the disease progresses,
sex, and gender differences can emerge in the incidence of clinical
features, such as postural instability or depressive symptoms
(8, 9). In addition to these differences in clinical phenotype,
coping styles may also vary between men and women with PD
(10). Given this broad spectrum of potential differences, the
consideration of sex- and gender-specific problems and needs of
people with PD appears to be essential to provide personalized
care. However, to date, empirical insight on the influence of sex
and gender on disease progression and care for people with PD
remains scarce.
This perspective paper addresses how sex and gender may
impact care for people with PD, drawing from both the PD
literature as well as from other fields of medicine. We will
specifically focus on the following domains: (1) motor features,
(2) non-motor features, (3) lifestyle, and (4) coping and informal
care. To illustrate the potential impact of sex or gender, we
highlight examples for which differences have been reported in
PD, although the level of evidence varies substantially. For each
section, the reviewed data on sex and gender differences in PD are
summarized, and considerations for multidisciplinary and sex-
and gender-sensitive care for people with PD are highlighted.
SEX AND GENDER ASPECTS IN PD
Sex and Gender Aspects in Motor Features
PD is primarily known as a clinical syndrome described as
“Parkinsonism,” which entails bradykinesia in combination with
at least one of the following: resting tremor, rigidity, or postural
instability (11, 12). As the disease progresses, people with PD are
prone to develop fluctuations in motor impairments related to
dopaminergic therapy, as well as to freezing of gait (13). Several
differences in motor features between men and women with
PD have been reported and have been summarized elsewhere
(8, 14, 15). However, the relevance of these differences for care
provision to people with PD remains largely unknown.
The potential impact of sex or gender differences on
multidisciplinary care for mobility impairments comes from
other fields of medicine, such as recent recommendations
for osteoporosis screening guidelines based on underlying
sex differences (16). Osteoporosis predominantly affects
postmenopausal females (17) but also impacts many elderly
males (18, 19). Given the higher mortality of men with bone
fractures, several osteoporosis, and endocrinology societies
now recommend screening in all men above 65 or 70 years
(19, 20), but this recommendation is not routinely implemented
in clinical practice (16).
Similarly, it is possible that sex or gender differences in the
prevalence of common motor features in PD may influence
clinical recommendations in the future. At themoment, however,
several gaps in empirical evidence hamper development of such
sex- and gender-sensitive guidelines. In Table 1, we highlight key
questions that, once addressed, could guide the implementation
of sex- and gender-sensitive approaches to care for people
with PD.
An illustration of the current gaps in knowledge is the
recent observation that postural instability appears to be more
common among women with PD than among men (8, 21). This
observation is based on a few relatively small studies, rendering
uncertainty on whether this reflects a true sex difference in the
prevalence of this feature. If larger studies replicated this finding,
it would encourage preferential referral of women with PD to
a physiotherapist for preventive and symptomatic interventions,
such as technology-assisted balance training. But for this selective
referral to be effective, we also need insight on whether the
effectiveness of symptomatic interventions differs between men
and women with PD. Future studies should be adequately
powered to examine clinically meaningful effect modification by
gender, which requires larger sample sizes.
Furthermore, knowledge about the impact of gender-specific
differences in activities of daily living (ADL) among people
with PD is relatively scarce. The available literature, however,
suggests that causal influences onADLmay differ substantially by
gender. For instance, women report greater difficulty shopping
and cleaning compared to men with PD, highlighting not only
the practical consequences of mobility impairment, but also
its gendered dimension (22). If these differences are replicated
in other studies, this would encourage the development of
gender-sensitive targeted occupational therapy interventions for
ADL impairment (23). Taken together, empirical evidence for
targeted care interventions which consider sex and gender
differences in mobility impairment could eventually influence
clinical guidelines for people with PD.
An additional area of potential sex- or gender-related
influences on care revolves around interactions between patients
and healthcare professionals. In the field of surgery, two gender-
related factors affect the indication for total joint arthroplasty
(24): less referral of women by their primary care physician, i.e.,
reflecting a potential bias on the side of the physician; and less
requests by women to undergo surgery, i.e., bias on the side of
the patient. A recent study suggests that women with PD are
less likely to undergo Deep Brain Stimulation (DBS) surgery than
men with PD (25, 26). This is of particular note given that the
current literature suggests that women may experience a greater
improvement in quality of life after DBS than men (9, 27). This
imbalance needs to be further investigated to remove potential
referral or request bias through targeted interventions on the
provider or patient side (26, 28).
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TABLE 1 | Considerations for sex- and gender sensitive multidisciplinary PD care.
Domain Feature(s) Reported to be more
common in
Possible sex- and gender sensitive
care intervention(s) for this feature




Poor balance Women • Referral to (technology-assisted)
balance training interventions
• Are differences between men and women taken
into account when assessing the effectiveness of
balance training intervention?
• Do men and women prefer different features in
technology-assisted balance
training interventions?
Dyskinesia Women • Deep brain stimulation • What are the underlying reasons for delayed
access to deep brain stimulation surgery, on
average, in women compared to men?
• Do underlying gender-biases influence the shared







Men • Reduction or discontinuation of
dopaminergic therapies
• Cognitive behavior therapy
• Are gender differences in ICBs due to different
disease entities or socially-accepted gender
behaviors?
• How are patients addressed and informed
about sex differences in response to dopamine
replacement therapies?
• Do sex or gender predict outcome in





Women • Referral for coping skills training e.g:
mindfulness-based interventions
• Social support interventions
• Do screening measures for depression and anxiety
take differences in gender roles into account?
• Do gender traits predict or affect the





Men • Regular weight self-monitoring
• Development and regular review of
diet plan
• Are differences in food choices and practices
between men and women taken into account in
weight monitoring?
• Do sex and gender aspects contribute to




Women • Exercise enhanced by motivational app
elements
• Physical exercise interventions
• Do exercise apps take different drivers and
motivations for exercise between men and women
into account?
• Do exercise apps take gender-specific triggers
and rewards into account in their design?
Care support Less informal
care resources
Women • Proactive identification of social network
and care capacities of the patient
• Referral to social support interventions/
cognitive behavioral therapy
• Are social support interventions taking gender-
specific drivers and motivators into account?
• Are there gender differences in social support
needs and social support perspection and how
are these taking into account?
Higher
caregiver strain
Women • Regular screening of caregiver burden
• Care giver education about disease
progress, symptoms and experiences
• Do screening measures of caregiver burden take
gender differences in caregiver experiences into
account?
• Are there gender differences in information and
education needs about disease progression and
(advanced) care planning?
Sex and Gender Aspects in Non-motor
Features
Although PD is widely (and inadvertently) perceived as
being primarily characterized by motor symptoms, non-motor
symptoms are actually at least as common, and importantly,
these can have a considerable impact on quality of life in
persons with PD. In this section, we discuss two examples that
highlight the potential impact of sex and gender differences
on multidisciplinary care for people with PD: impulse control
disorders and depressive symptoms.
Impulse control behaviors (ICBs) are associated with
dopamine replacement therapy in PD. Overall, ICBs are
generally more common in men compared to women with PD
(29). However, the direction of these differences might differ
by the specific type ICB: hypersexuality and gambling are more
common in men, while compulsive buying is more common
in women (30). Analogous differences have been reported
for compulsive disorders in people without PD, with women
presenting more contamination/cleaning symptoms or eating
disorders whereas men more commonly present with sexual and
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aggressive symptoms (31, 32). It remains to be investigated if
these differences are due to different disease entities or simply to
socially-acceptable gendered behaviors (Table 1).
Depressive symptoms and anxiety are among the most
common non-motor symptoms in people with PD (33, 34).
Depressive symptoms and anxiety in PD are likely to be
multifactorial, related to the influence of PD pathology and the
indirect impact of impaired mobility and social isolation (35, 36).
Sex differences in depression have been linked to differences
in expression of susceptibility genes and hormonal influences
as well as gender-related differences in reporting (37, 38).
Although females and males with PD experience similar physical
symptoms, the associated psychological burden appears to differ.
Men primarily report difficulties in self-presentation, whereas
women report greater psychological burden and larger impact
on their intimate relationships (39, 40). This associates with a
significant reduction in quality of life in women with PD (41).
Also, higher anxiety levels have been reported in women with PD,
especially in the early clinical phase of the disease (42–44).
However, to date, the impact of sex and gender differences
in anxiety and depressive symptoms on care provision for
people with PD has remained limited. Again, the field of PD
is not unique in this regard. In 2008, the masculine depression
scale (MDS) was developed to facilitate diagnosis of masculine
depressive symptoms (45). A recent study found that men and
women who endorse a masculine gender role are relatively more
likely to display externalizing symptoms (e.g., anger, somatic
symptoms, using substance, or sex to feel better) in response to
negative life events, and less likely to report typical, internalizing
depressive symptoms, as measured by, e.g., the widely used
Beck Depression Inventory (e.g., depressed mood or crying)
(46). Therefore, clinicians should be aware that individuals who
strongly adhere to masculine gender roles, whether they be men
or women, might display different signs and symptoms and may
respond differently to behavioral interventions for depression
and anxiety than individuals who adhere more strongly to a
feminine gender role (Table 1).
Gender Aspects in Lifestyle
Few differences in lifestyle between men and women with PD
have been reported. In this section, we discuss two examples
that highlight the potential impact of such differences on
multidisciplinary care for people with PD: weight loss and
physical activity.
Progressive weight loss is common among people with PD,
likely due to a combination of physical inactivity (causing muscle
loss), lower intake of solid foods due to oropharyngeal dysphagia
and a catabolic state (15, 47). A decreased intake of solid foods
may result in less consumption of fresh foods and vegetables,
which leads to a risk of malnutrition (47). Researchers in other
fields consistently reported healthier food choices among women
compared to men, including increased consumption of fresh
fruit and vegetables and reduced consumption of processed
food and alcohol (48, 49). Encouragement by nutritionists of
the consumption of healthy, solid, foods should consider these
gender norms, as well as direct assessment of the abililty to
prepare and consume foods due to disease-related physical
limitations. Again, this is an area in which a gender-sensitive
care intervention for people with PD could be informed by
data from other fields. However, to our knowledge, no studies
have examined the effectiveness of gender-sensitive approaches
to nutrition among people with PD to date.
Once validated, gender-sensitive approaches may also help to
better understand differences in body weight related impairments
between men and women with PD. A useful example here
comes from the field of cardiometabolic diseases, in which the
observation of body fat distribution differences between women
and men led to the identification of the hip-to-waist ratio as a
better predictor of risk than BMI, especially for women (50).
Among people with PD, weight loss generally associates with
highermortality and worse quality of life (51).While unexplained
weight change is reported more commonly in women with
PD (52, 53), clinically significant weight loss is reported to be
associated with lower 1-year survival rates in men, compared to
women with PD (54). Future studies should examine the sex-
specific prognostic utility of weight loss among people with PD.
Gender considerations are also relevant in the context of
physical activity. Women worldwide appear to engage less
frequently in physical activity compared to men (55). Different
drivers can modulate the uptake of physical activity in women
and men with PD. Women appear to rely on enjoyment as the
primarymotivator whilemen describe self-efficacy as the primary
driver for physical activity (56). In different regions, gender-
related factors might also be at play. For example, in a qualitative
study in Jordan, women with PD reported family commitment
and support as important elements to initiate and maintain an
exercise program. However, gender norms acted as barriers as
unequal division of household tasks and childcare limited the
time available for exercise (57). Different motivation strategies
might be needed for women and men with PD and gender norms
should be made explicit to reduce barriers to exercise (Table 1).
Examples could be drawn from gender-sensitive programs to
increase physical activity and promote healthy weight such
as WISEWOMAN in the United States and Football Fans in
Training (FFIT) in the UK (58, 59).
Gender Aspects in Coping and Informal
Care
Several differences in caremanagement betweenmen andwomen
with PD have been reported. In this section, we discuss two
examples that highlight the potential impact of such differences
on multidisciplinary care for people with PD: coping strategies
and informal care.
Gender can influence individual coping strategies and should
be taken into account in systematically measuring differences in
distress and coping (43). General studies on gender differences
coping strategies are conflicting. Some authors report that
women use more emotion-focused coping strategies while men
prefer focusing on avoidant coping (60, 61). However, a study
targeting coping strategies among people with PD reported the
opposite, with women reporting more problem-focused coping
strategies compared to males (10). Interestingly, less polarized
gender roles might associate with better quality of life in women.
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Specifically, androgynous women with PD, expressing masculine
and feminine personality traits equally, scored significantly better
on quality of life than androgynous men with PD (62). Similar
to the impact of gender roles on the reponse to negative life
events in the context of depression, clinicians should be aware
of the potential impact of gender roles on (in)effective coping
strategies. Additionally, researchers should continue to explore
the impact of different gender dimensions on coping strategies
and health-related quality of life in people with PD.
In the context of informal care, women with PD report less
social support and less informal caregiving resources compared
to men (8). Women worldwide are still more frequently active
caregivers than men, although this is changing in younger
generations (63). Previous studies describe fewer negative
outcomes and less impaired quality of life in male caregivers (64,
65). Women caregivers reported exhaustion, social constraints,
and time limitations more frequently than men and women
report more adverse consequences from the progression of
the disease of their partners, such as feelings of manipulation,
excessive demands, and lack of freedom (38). One study noted
that women caregivers appeared to experience a higher incidence
of depression and dysfunctional fear of progression compared
to men caregivers (66), but another failed to find any gender
differences in psychological, social, and health outcomes (67).
Progression of disease and the potentially associated cognitive
decline, which is higher in men with PD compared to women,
also places a higher burden on caregivers with potential impact
on their health (14, 68–71).
Proactive identification of social network and care capacities
of the patient, for example by a PD nurse specialist, is
needed to prevent gender disparaties in care support (Table 1).
Furthermore, caregiver strain might affect female and male
caregivers differently. This aspect should be actively explored,
as caregivers might refrain from addressing it directly. Targeted
options such as logistic support through social workers and social
support through caregiver associations, should be discussed
with caregivers. Psychological and educational support might be
needed and should be proactively addressed with the caregiver
(Table 1).
DISCUSSION
In this perspective paper, we highlight the potential impact
of sex and gender on care for people with PD, and identify
key knowledge gaps that hamper immediate implementation of
sex- or gender-sensitive approaches. The intersection between
biological differences and social norms and behaviors highlights
the complexity of individualized care. Although knowledge in
the area of sex and gender differences is increasing, the current
state of evidence does not yet allow for specific recommendations
for sex- and gender sensitive approaches for individual patients.
In the case of PD, few studies have focused on the role of
gender and the ones that did, lacked a clear definition of the
concept of gender itself. Gender consists of several dimensions,
such as identity, roles, and relations, and these should be
clearly defined and operationalized when embarking into its
investigation (72). As the previously described studies on quality
of life demonstrated, gender rather then sex was predictive (62).
This is in line with findings in the field of cardiology and
highlights the continuous nature of the concept opposed to
the simple man/woman dichotomy (73). More methodological
precision in the analysis of sex and gender differences in PD will
aid the transferability of the acquired knowledge into practical
steps toward individualized care.
Furthermore, while the prevalence of PD has typically
been higher in men than in women in clinical studies,
population-based studies which include door-to-door screening
and validation have demonstrated a markedly smaller gender
difference in the prevalence of PD (3, 74). This discrepancy
suggests that women with PD are not being referred to clinical
settings as readily as men. In fact, a previous study showed that
there is a considerable delay in referral of women with PD to
movement disorder specialists (75). Furthermore, women are
also underrepresented in clinical trials on PD and efforts to bridge
this gender gap in future RCTs should be undertaken (76).
The present perspective has highlighted various areas in need
of additional research. Gender-specific preferences and priorities
in health care provision need to be further investigated. Which
symptoms are more burdening for women and men with PD
and which potential barriers exist toward optimal care provision?
Are there gender-specific dimensions that contribute to long-
term maintenance of quality of life? How do gender roles impact
the patient’s choices and can addressing them affect coping
strategies? Answers to these important questions could support
further refinement of multidisciplinary care programs tailored
specifically to the needs of people with PD and remove potential
unconscious gender-specific barriers.
DATA AVAILABILITY STATEMENT
The original contributions presented in the study are included
in the article/supplementary material, further inquiries can be
directed to the corresponding author/s.
AUTHOR CONTRIBUTIONS
SO-P and SD contributed to conception and design of the study.
SO-P and IG performed the literature review and wrote the first
draft of the manuscript. SO-P, IG, SD, and AH wrote sections of
the manuscript. All authors contributed to manuscript revision,
read, and approved the submitted version.
FUNDING
All authors are part of the collaborative PRIME Parkinson
project (grant no. PF-FBS-2026), which is financed by the
Gatsby Foundation and the Dutch Ministry of Economic
Affairs by means of the PPP Allowance made available by the
Top Sector Life Sciences & Health to stimulate public-private
partnerships. The Center of Expertise for Parkinson&Movement
Disorders was supported by a center of excellence grant of the
Parkinson Foundation.
Frontiers in Neurology | www.frontiersin.org 5 September 2020 | Volume 11 | Article 576121
Göttgens et al. Sex and Gender in Parkinson
REFERENCES
1. Oertelt-Prigione S, Regitz-Zagrosek V. Sex and Gender Aspects in Clinical
Medicine. Sex and Gender in Medical Literature. London: Springer (2013).
p. 9–17. doi: 10.1007/978-0-85729-832-4
2. Tannenbaum C, Ellis RP, Eyssel F, Zou J, Schiebinger L. Sex and gender
analysis improves science and engineering. Nature. (2019) 575:137–46.
doi: 10.1038/s41586-019-1657-6
3. GBD 2016. Parkinson’s Disease collaborators. Global, regional, and national
burden of Parkinson’s disease, 1990-2016: a systematic analysis for the
Global Burden of Disease Study 2016. Lancet Neurol. (2018) 17:939–53.
doi: 10.1016/S1474-4422(18)30295-3
4. van der Eijk M, Nijhuis FAP, Faber MJ, Bloem BR. Moving from
physician-centered care towards patient-centered care for Parkinson’s
disease patients. Parkinsonism Relat Disord. (2013) 19:923–7.
doi: 10.1016/j.parkreldis.2013.04.022
5. Vlaanderen FP, Rompen L, Munneke M, Stoffer M, Bloem BR, Faber MJ.
The voice of the parkinson customer. J Parkinsons Dis. (2019) 9:197–201.
doi: 10.3233/JPD-181431
6. van der Marck MA, Kalf JG, Sturkenboom IHWM, Nijkrake MJ, Munneke
M, Bloem BR. Multidisciplinary care for patients with Parkinson’s
disease. Parkinsonism Relat Disord. (2009) 15(Suppl. 3):S219–23.
doi: 10.1016/S1353-8020(09)70819-3
7. Radder DLM, de Vries NM, Riksen NP, Diamond SJ, Gross D, Gold
DR, et al. Multidisciplinary care for people with Parkinson’s disease:
the new kids on the block! Expert Rev Neurother. (2019) 19:145–57.
doi: 10.1080/14737175.2019.1561285
8. Cerri S, Mus L, Blandini F. Parkinson’s disease in women and men: what’s the
difference? J Parkinsons Dis. (2019) 9:501–15. doi: 10.3233/JPD-191683
9. Georgiev D, Hamberg K, Hariz M, Forsgren L, Hariz G-M. Gender differences
in Parkinson’s disease: A clinical perspective. Acta Neurol Scand. (2017)
136:570–84. doi: 10.1111/ane.12796
10. Anzaldi K, Shifren K. Optimism, pessimism, coping, and depression: a study
on individuals with Parkinson’s disease. Int J Aging Hum Dev. (2019) 88:231–
49. doi: 10.1177/0091415018763401
11. Muslimovic D, Post B, Speelman JD, Schmand B, de Haan RJ. Determinants of
disability and quality of life in mild to moderate Parkinson disease.Neurology.
(2008) 70:2241–7. doi: 10.1212/01.wnl.0000313835.33830.80
12. Karlsen KH, Tandberg E, Arsland D, Larsen JP. Health related quality of life
in Parkinson’s disease: a prospective longitudinal study. J Neurol Neurosurg
Psychiatry. (2000) 69:584–9. doi: 10.1136/jnnp.69.5.584
13. Nonnekes J, Snijders AH, Nutt JG, Deuschl G, Giladi N, Bloem BR. Freezing
of gait: a practical approach to management. Lancet Neurol. (2015) 14:768–78.
doi: 10.1016/S1474-4422(15)00041-1
14. Pavon JM, Whitson HE, Okun MS. Parkinson’s disease in women: a call
for improved clinical studies and for comparative effectiveness research.
Maturitas. (2010) 65:352–8. doi: 10.1016/j.maturitas.2010.01.001
15. Gillies GE, Pienaar IS, Vohra S, Qamhawi Z. Sex differences
in Parkinson’s disease. Front Neuroendocrinol. (2014) 35:370–84.
doi: 10.1016/j.yfrne.2014.02.002
16. Alswat KA. Gender disparities in osteoporosis. J ClinMed Res. (2017) 9:382–7.
doi: 10.14740/jocmr2970w
17. Jackson RD, Mysiw WJ. Insights into the epidemiology of postmenopausal
osteoporosis: the women’s health initiative. Semin ReprodMed. (2014) 32:454–
62. doi: 10.1055/s-0034-1384629
18. Alswat K, Adler SM. Gender differences in osteoporosis
screening: retrospective analysis. Arch Osteoporos. (2012) 7:311–3.
doi: 10.1007/s11657-012-0113-0
19. Willson T, Nelson SD, Newbold J, Nelson RE, LaFleur J. The clinical
epidemiology of male osteoporosis: a review of the recent literature. Clin
Epidemiol. (2015) 7:65–76. doi: 10.2147/CLEP.S40966
20. Watts NB, Adler RA, Bilezikian JP, Drake MT, Eastell R, Orwoll ES, et al.
Osteoporosis in men: an endocrine society clinical practice guideline. J Clin
Endocrinol Metab. (2012) 97:1802–22. doi: 10.1210/jc.2011-3045
21. Szewczyk-Krolikowski K, Tomlinson P, Nithi K, Wade-Martins R, Talbot K,
Ben-Shlomo Y, et al. The influence of age and gender on motor and non-
motor features of early Parkinson’s disease: Initial findings from the Oxford
ParkinsonDisease Center (OPDC) discovery cohort. Park Relat Disord. (2014)
20:99–105. doi: 10.1016/j.parkreldis.2013.09.025
22. Sperens M, Georgiev D, Eriksson Domellöf M, Forsgren L, Hamberg K, Hariz
G-M. Activities of daily living in Parkinson’s disease: time/gender perspective.
Acta Neurol Scand. (2020) 141:168–76. doi: 10.1111/ane.13189
23. Radder DLM, Sturkenboom IH, van Nimwegen M, Keus SH, Bloem BR, de
Vries NM. Physical therapy and occupational therapy in Parkinson’s disease.
Int J Neurosci. (2017) 127:930–43. doi: 10.1080/00207454.2016.1275617
24. Borkhoff CM, Hawker GA, Wright JG. Patient gender affects the referral and
recommendation for total joint arthroplasty. Clin Orthop Relat Res. (2011)
469:1829–37. doi: 10.1007/s11999-011-1879-x
25. Hassin-Baer S, Molchadski I, Cohen OS, Nitzan Z, Efrati L, Tunkel O, et al.
Gender effect on time to levodopa-induced dyskinesias. J Neurol. (2011)
258:2048–53. doi: 10.1007/s00415-011-6067-0
26. Shpiner DS, Di Luca DG, Cajigas I, Diaz JS, Margolesky J, Moore H,
et al. Gender disparities in deep brain stimulation for Parkinson’s disease.
Neuromodulation. (2019) 22:484–8. doi: 10.1111/ner.12973
27. Hariz G-M, Limousin P, Zrinzo L, Tripoliti E, Aviles-Olmos I, Jahanshahi
M, et al. Gender differences in quality of life following subthalamic
stimulation for Parkinson’s disease. Acta Neurol Scand. (2013) 128:281–5.
doi: 10.1111/ane.12127
28. Hamberg K, Hariz G-M. The decision-making process leading to deep brain
stimulation in men and women with parkinson’s disease - an interview study.
BMC Neurol. (2014) 14:89. doi: 10.1186/1471-2377-14-89
29. Kon T, Ueno T, Haga R, Tomiyama M. The factors associated with impulse
control behaviors in Parkinson’s disease: a 2-year longitudinal retrospective
cohort study. Brain Behav. (2018) 8:e01036. doi: 10.1002/brb3.1036
30. Bhattacharjee S. Impulse control disorders in Parkinson’s disease: Review
of pathophysiology, epidemiology, clinical features, management, and future
challenges. Neurol India. (2018) 66:967–75. doi: 10.4103/0028-3886.237019
31. Mathis MA de, Alvarenga P de, Funaro G, Torresan RC, Moraes I, Torres AR,
et al. Gender differences in obsessive-compulsive disorder: a literature review.
Rev Bras Psiquiatr. (2011) 33:390–9. doi: 10.1590/S1516-44462011000400014
32. Mathes BM, Morabito DM, Schmidt NB. Epidemiological and clinical
gender differences in OCD. Curr Psychiatry Rep. (2019) 21:1–7.
doi: 10.1007/s11920-019-1015-2
33. Mele B, Holroyd-Leduc J, Smith EE, Pringsheim T, Ismail Z, Goodarzi Z.
Detecting anxiety in individuals with Parkinson disease: a systematic review.
Neurology. (2018) 90:e39–47. doi: 10.1212/WNL.0000000000004771
34. Schapira AHV, Chaudhuri KR, Jenner P. Non-motor features of Parkinson
disease. Nat Rev Neurosci. (2017) 18:435–50. doi: 10.1038/nrn.2017.62
35. Marsh L. Depression and Parkinson’s disease: current knowledge. Curr Neurol
Neurosci Rep. (2013) 13:409. doi: 10.1007/s11910-013-0409-5
36. Mayberg HS, Solomon DH. Depression in Parkinson’s disease: a biochemical
and organic viewpoint. Adv Neurol. (1995) 65:49–60.
37. Labaka A, Goñi-Balentziaga O, Lebeña A, Pérez-Tejada J. Biological sex
differences in depression: a systematic review. Biol Res Nurs. (2018) 20:383–92.
doi: 10.1177/1099800418776082
38. Balash Y, Korczyn AD, Migirov AA, Gurevich T. Quality of life in Parkinson’s
disease: a gender-specific perspective. Acta Neurol Scand. (2019) 140:17–22.
doi: 10.1111/ane.13095
39. Solimeo S. Sex and gender in older adults’ experience of parkinson’s
disease. J Gerontol - Ser B Psychol Sci Soc Sci. (2008) 63:42–8.
doi: 10.1093/geronb/63.1.S42
40. Scott B, Borgman A, Engler H, Johnels B, Aquilonius SM. Gender differences
in Parkinson’s disease symptom profile. Acta Neurol Scand. (2000) 102:37–43.
doi: 10.1034/j.1600-0404.2000.102001037.x
41. Rojo A, Aguilar M, Garolera MT, Cubo E, Navas I, Quintana S. Depression in
Parkinson’s disease: clinical correlates and outcome. Park Relat Disord. (2003)
10:23–8. doi: 10.1016/S1353-8020(03)00067-1
42. Baba Y, Putzke JD, Whaley NR, Wszolek ZK, Uitti RJ. Gender and
the Parkinson’s disease phenotype. J Neurol. (2005) 252:1201–5.
doi: 10.1007/s00415-005-0835-7
43. Abraham DS, Gruber-Baldini AL, Magder LS, McArdle PF, Tom
SE, Barr E, et al. Sex differences in Parkinson’s disease presentation
and progression. Parkinsonism Relat Disord. (2019) 69:48–54.
doi: 10.1016/j.parkreldis.2019.10.019
Frontiers in Neurology | www.frontiersin.org 6 September 2020 | Volume 11 | Article 576121
Göttgens et al. Sex and Gender in Parkinson
44. Farabaugh AH, Locascio JJ, Yap L, Weintraub D, McDonaldWM, Agoston M,
et al. Pattern of depressive symptoms in Parkinson’s disease. Psychosomatics.
(2009) 50:448–54. doi: 10.1016/S0033-3182(09)70836-9
45. Magovcevic M, Addis ME. The masculine depression scale: development
and psychometric evaluation. Psychol Men Masc. (2008) 9:117–32.
doi: 10.1037/1524-9220.9.3.117
46. Price EC, Gregg JJ, Smith MD, Fiske A. Masculine traits and depressive
symptoms in older and younger men and women. Am J Mens Health. (2018)
12:19–29. doi: 10.1177/1557988315619676
47. Lorefält B, Granérus A-K, Unosson M. Avoidance of solid food in weight
losing older patients with Parkinson’s disease. J Clin Nurs. (2006) 15:1404–12.
doi: 10.1111/j.1365-2702.2005.01454.x
48. Westenhoefer J. Age and gender dependent profile of food choice. Forum
Nutr. (2005) 57:44–51. doi: 10.1159/000083753
49. Wardle J, Haase AM, Steptoe A, Nillapun M, Jonwutiwes K, Bellisle F.
Gender differences in food choice: the contribution of health beliefs and
dieting. Ann Behav Med. (2004) 27:107–16. doi: 10.1207/s15324796abm
2702_5
50. Peters SAE, Bots SH, Woodward M. Sex differences in the association
between measures of general and central adiposity and the risk of myocardial
infarction: results from the UK Biobank. J Am Heart Assoc. (2020) 7:e008507.
doi: 10.1161/JAHA.117.008507
51. Sharma JC, Vassallo M. Prognostic significance of weight changes in
Parkinson’s disease: the Park-weight phenotype. Neurodegener Dis Manag.
(2014) 4:309–16. doi: 10.2217/nmt.14.25
52. Durcan R, Wiblin L, Lawson RA, Khoo TK, Yarnall AJ, Duncan GW, et al.
Prevalence and duration of non-motor symptoms in prodromal Parkinson’s
disease. Eur J Neurol. (2019) 26:979–85. doi: 10.1111/ene.13919
53. Lorefält B, Ganowiak W, Pålhagen S, Toss G, Unosson M, Granérus
A-K. Factors of importance for weight loss in elderly patients
with Parkinson’s disease. Acta Neurol Scand. (2004) 110:180–7.
doi: 10.1111/j.1600-0404.2004.00307.x
54. Walker R, Davidson M, Gray W. Gender differences in 1-year survival rates
after weight loss in people with idiopathic Parkinson’s disease. Int J Palliat
Nurs. (2012) 18:35–9. doi: 10.12968/ijpn.2012.18.1.35
55. Guthold R, Stevens GA, Riley LM, Bull FC. Worldwide trends in insufficient
physical activity from 2001 to 2016: a pooled analysis of 358 population-based
surveys with 1·9 million participants. Lancet Glob Heal. (2018) 6:e1077–86.
doi: 10.1016/S2214-109X(18)30357-7
56. Urell C, Zetterberg L, Hellström K, Anens E. Factors explaining physical
activity level in Parkinson’s disease: a gender focus. Physiother Theory Pract.
(2019). doi: 10.1080/09593985.2019.1630875. [Epub ahead of print].
57. Khalil H, Nazzal M, Al-Sheyab N. Parkinson’s disease in Jordan: barriers
and motivators to exercise. Physiother Theory Pract. (2016) 32:509–19.
doi: 10.1080/09593985.2016.1219433
58. Will JC, Farris RP, Sanders CG, Stockmyer CK, Finkelstein EA.
Health promotion interventions for disadvantaged women: overview
of the WISEWOMAN projects. J Womens Health. (2004) 13:484–502.
doi: 10.1089/1540999041281025
59. Hunt K, Wyke S, Gray CM, Anderson AS, Brady A, Bunn C, et al. A
gender-sensitised weight loss and healthy living programme for overweight
and obese men delivered by Scottish Premier League football clubs (FFIT):
a pragmatic randomised controlled trial. Lancet. (2014) 383:1211–21.
doi: 10.1016/S0140-6736(13)62420-4
60. Eaton RJ, Bradley G. The role of gender and negative affectivity in stressor
appraisal and coping selection. Int J Stress Manag. (2008) 15:94–115.
doi: 10.1037/1072-5245.15.1.94
61. Kelly MM, Tyrka AR, Price LH, Carpenter LL. Sex differences in the use
of coping strategies: predictors of anxiety and depressive symptoms. Depress
Anxiety. (2008) 25:839–46. doi: 10.1002/da.20341
62. Moore O, Kreitler S, Ehrenfeld M, Giladi N. Quality of life and gender
identity in Parkinson’s disease. J Neural Transm. (2005) 112:1511–22.
doi: 10.1007/s00702-005-0285-5
63. Sharma N, Chakrabarti S, Grover S. Gender differences in caregiving among
family - caregivers of people with mental illnesses. World J Psychiatry. (2016)
6:7–17. doi: 10.5498/wjp.v6.i1.7
64. Hooker K, Manoogian-O’Dell M, Monahan DJ, Frazier LD, Shifren K.
Does type of disease matter? Gender differences among Alzheimer’s and
Parkinson’s disease spouse caregivers. Gerontologist. (2000) 40:568–73.
doi: 10.1093/geront/40.5.568
65. Morley D, Dummett S, Peters M, Kelly L, Hewitson P, Dawson J, et al. Factors
influencing quality of life in caregivers of people with Parkinson’s disease and
implications for clinical guidelines. Jahanshahi M, editor. Park Dis. (2012)
2012:190901. doi: 10.1155/2012/190901
66. Braukhaus C, Jahnke U, Zimmermann T. [Relationship strain
Parkinson’s disease! gender-specific distress of partners of patients with
Parkinson’s disease]. Psychother Psychosom Med Psychol. (2018) 68:250–7.
doi: 10.1055/s-0043-114860
67. O’Reilly F, Finnan F, Allwright S, Smith GD, Ben-Shlomo Y. The effects of
caring for a spouse with Parkinson’s disease on social, psychological and
physical well-being. Br J Gen Pract. (1996) 46:507–12.
68. Leroi I, McDonald K, Pantula H, Harbishettar V. Cognitive impairment in
Parkinson disease: impact on quality of life, disability, and caregiver burden. J
Geriatr Psychiatry Neurol. (2012) 25:208–14. doi: 10.1177/0891988712464823
69. Corallo F, De Cola MC, Lo Buono V, Di Lorenzo G, Bramanti P, Marino
S. Observational study of quality of life of Parkinson’s patients and their
caregivers. Psychogeriatrics. (2017) 17:97–102. doi: 10.1111/psyg.12196
70. Cereda E, Cilia R, Klersy C, Siri C, Pozzi B, Reali E, et al. Dementia in
Parkinson’s disease: is male gender a risk factor? Parkinsonism Relat Disord.
(2016) 26:67–72. doi: 10.1016/j.parkreldis.2016.02.024
71. Cholerton B, Johnson CO, Fish B, Quinn JF, Chung KA, Peterson-Hiller
AL, et al. Sex differences in progression to mild cognitive impairment and
dementia in Parkinson’s disease. Parkinsonism Relat Disord. (2018) 50:29–36.
doi: 10.1016/j.parkreldis.2018.02.007
72. Tannenbaum C, Greaves L, Graham ID. Why sex and gender matter
in implementation research. BMC Med Res Methodol. (2016) 16:145.
doi: 10.1186/s12874-016-0247-7
73. Pelletier R, Khan NA, Cox J, Daskalopoulou SS, Eisenberg MJ, Bacon SL,
et al. Sex versus gender-related characteristics: which predicts outcome after
acute coronary syndrome in the young? J Am Coll Cardiol. (2016) 67:127–35.
doi: 10.1016/j.jacc.2015.10.067
74. Pringsheim T, Jette N, Frolkis A, Steeves TDL. The prevalence of Parkinson’s
disease: a systematic review and meta-analysis. Mov Disord. (2014) 29:1583–
90. doi: 10.1002/mds.25945
75. Saunders-Pullman R, Wang C, Stanley K, Bressman SB. Diagnosis and
referral delay in women with Parkinson’s disease. Gend Med. (2011) 8:209–17.
doi: 10.1016/j.genm.2011.05.002
76. Tosserams A, Araújo R, Pringsheim T, Post B, Darweesh SKL, IntHout J,
et al. Underrepresentation of women in Parkinson’s disease trials.Mov Disord.
(2018) 33:1825–6. doi: 10.1002/mds.27505
Conflict of Interest: BB has received honoraria from serving on the scientific
advisory board for Abbvie, Biogen, and UCB, has received fees for speaking at
conferences from AbbVie, Zambon, Roche, GE Healthcare and Bial.
The remaining authors declare that the research was conducted in the absence of
any commercial or financial relationships that could be construed as a potential
conflict of interest.
Copyright © 2020 Göttgens, van Halteren, de Vries, Meinders, Ben-Shlomo, Bloem,
Darweesh and Oertelt-Prigione. This is an open-access article distributed under the
terms of the Creative Commons Attribution License (CC BY). The use, distribution
or reproduction in other forums is permitted, provided the original author(s) and
the copyright owner(s) are credited and that the original publication in this journal
is cited, in accordance with accepted academic practice. No use, distribution or
reproduction is permitted which does not comply with these terms.
Frontiers in Neurology | www.frontiersin.org 7 September 2020 | Volume 11 | Article 576121
